Google Research has developed the VERID framework enabling AI agents to design and run experiments in physical laboratories autonomously. Testing aptamers targeting α-thrombin, the hit rate climbed from 0% in the first round to 42.1% in the third, at a cost of $1 to $3 per candidate. The team then applied this approach to de-novo protein design for cancer-related proteins, achieving single-digit nanomolar binding affinities. On October 7, 2026, a coalition including Google DeepMind, Meta, Isomorphic Labs, and US government partners announced a $1.8 billion investment in the Virtual Biology Initiative.
Source: Read the original article
Disclaimer: this content is for information purposes only and is not financial advice. Cryptocurrencies are highly volatile: you may lose all of your capital. Always do your own research. Legal notice
